Clinical Study

Pancreas-Preserving Approach to “Paraduodenal Pancreatitis” Treatment: Why, When, and How? Experience of Treatment of 62 Patients with Duodenal Dystrophy

Figure 8

Microphotograph. Patient 53 y.o. Duodenal dystrophy with chronic orthotopic pancreatitis. (a) Ectopic pancreatic tissue (В) in the duodenal wall (A) is presented by acinar-ductal transformation and reaches duodenal mucosa lamina propria (C). Hematoxylin-eosin, ×50; (b) fibrosis and inflammatory infiltration in the ectopic pancreatic tissue in the duodenal wall (B) and at the periphery. Hematoxylin-eosin, ×50; (c) prominent atrophy of the acinar tissue with duct transformation (black arrows) and adenomatous hyperplasia of the epithelium (circle). Hematoxylin-eosin, ×100.
185265.fig.008a
(a)
185265.fig.008b
(b)
185265.fig.008c
(c)